Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?

被引：106

作者：

Avet-Loiseau, Herve ^{[1
,2
]}

Malard, Florent ^{[2
]}

Campion, Loic ^{[3
]}

Magrangeas, Florence ^{[2
]}

Sebban, Catherine ^{[4
]}

Lioure, Bruno ^{[5
]}

Decaux, Olivier ^{[6
]}

Lamy, Thierry ^{[7
]}

Legros, Laurence ^{[8
]}

Fuzibet, Jean-Gabriel ^{[9
]}

Michallet, Mauricette ^{[10
]}

Corront, Bernadette ^{[11
]}

Lenain, Pascal ^{[12
]}

Hulin, Cyrille ^{[13
]}

Mathiot, Claire ^{[14
]}

Attal, Michel ^{[15
]}

Facon, Thierry ^{[16
]}

Harousseau, Jean-Luc ^{[17
]}

Minvielle, Stephane ^{[2
]}

Moreau, Philippe ^{[18
]}

机构：

[1] Univ Hosp, Hematol Lab, Inst Biol, F-44093 Nantes, France

[2] INSERM, U892, Nantes, France

[3] Ctr Rene Gauducheau, Dept Stat, F-44035 Nantes, France

[4] Ctr Leon Berard, Dept Hematol, F-69373 Lyon, France

[5] Univ Hosp, Dept Hematol, Strasbourg, France

[6] Univ Hosp, Dept Internal Med, Rennes, France

[7] Univ Hosp, Dept Hematol, Rennes, France

[8] Univ Hosp, Dept Hematol, Nice, France

[9] Univ Hosp, Dept Internal Med, Nice, France

[10] Univ Hosp, Dept Hematol, Lyon, France

[11] Univ Hosp, Dept Hematol, Annecy, France

[12] Ctr Francois Baclesse, Dept Hematol, Rouen, France

[13] Univ Hosp, Dept Hematol, Nancy, France

[14] Inst Curie, Hematol Lab, Paris, France

[15] Univ Hosp, Dept Hematol, Toulouse, France

[16] Univ Hosp, Dept Hematol, Lille, France

[17] Ctr Rene Gauducheau, Dept Hematol, F-44035 Nantes, France

[18] Univ Hosp, Dept Hematol, Nantes, France

来源：

BLOOD | 2011年 / 117卷 / 06期

关键词：

STEM-CELL TRANSPLANTATION; C-MAF; MAINTENANCE; THALIDOMIDE; EXPRESSION; SURVIVAL; THERAPY; TRIAL; GENE;

D O I：

10.1182/blood-2010-07-295105

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Many trials in myeloma are stratified on cytogenetic abnormalities. Among them, the most commonly chosen are the t(4;14), the del(17p), and the t(14;16). If data are well established for t(4;14) and del(17p), very few data support the use of t(14;16). To address this issue, we retro-spectively analyzed 1003 patients with newly diagnosed myeloma for this abnormality. We identified 32 patients with the t(14;16). Compared with patients lacking the t(14;16), we did not observe any difference in overall survival (P = .28). Moreover, in multivariate analyses, the t(14;16) was not prognostic (P = .39). In conclusion, our data do not support the use of t(14;16)-specific probes in the diagnostic panels of multiple myeloma. (Blood. 2011; 117(6): 2009-2011)

引用

页码：2009 / 2011

页数：3

共 50 条

[1] Translocation t(4; 14) and multiple myeloma : is it a new independent prognostic factor?
Manier, Salomon
Leleu, Xavier
HEMATOLOGIE, 2011, 17 (01): : 17 - 17
[2] Translocation t(14;16) in IgM multiple myeloma
Owen, Roger G.
O'Connor, Sheila J. M.
Bond, Lee R.
de Tute, Ruth M.
Rawstron, Andy C.
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (03) : 402 - 403
[3] Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions
Anaïs Schavgoulidze
Aurore Perrot
Titouan Cazaubiel
Xavier Leleu
Lydia Montes
Caroline Jacquet
Karim Belhadj
Sabine Brechignac
Laurent Frenzel
Thomas Chalopin
Philippe Rey
Jean-Marc Schiano de Collela
Mamoun Dib
Denis Caillot
Margaret Macro
Jean Fontan
Laure Buisson
Luka Pavageau
Murielle Roussel
Salomon Manier
Mohamad Mohty
Ludovic Martinet
Hervé Avet-Loiseau
Jill Corre
Blood Cancer Journal, 13
[4] Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions
Schavgoulidze, Anais
Perrot, Aurore
Cazaubiel, Titouan
Leleu, Xavier
Montes, Lydia
Jacquet, Caroline
Belhadj, Karim
Brechignac, Sabine
Frenzel, Laurent
Chalopin, Thomas
Rey, Philippe
Schiano de Collela, Jean-Marc
Dib, Mamoun
Caillot, Denis
Macro, Margaret
Fontan, Jean
Buisson, Laure
Pavageau, Luka
Roussel, Murielle
Manier, Salomon
Mohty, Mohamad
Martinet, Ludovic
Avet-Loiseau, Herve
Corre, Jill
BLOOD CANCER JOURNAL, 2023, 13 (01)
[5] TRANSLOCATION T(14;16): FREQUENCY AND SIGNIFICANCE IN PATIENTS WITH MULTIPLE MYELOMA
Mickova, P.
Balcarkova, J.
Pika, T.
Holzerova, M.
Nevimova, K.
Scudla, V.
Indrak, K.
Jarosova, M.
HAEMATOLOGICA, 2013, 98 : 592 - 593
[6] Real world evidence of prognostic impact of t(14;16) translocation in multiple myeloma: a report of the myeloma triveneto working group
Barila, Gregorio
Bonaldi, Laura
Pavan, Laura
Martines, Annalisa
Pascarella, Anna
Vedovato, Susanna
Clissa, Cristina
Marcon, Chiara
Furlan, Anna
Perbellini, Omar
Febbo, Massimiliano Arangio
Scomazzon, Edoardo
Berno, Tamara
Tinelli, Martina
Massarotti, Luca
Bonalumi, Angela
Trentin, Livio
Krampera, Mauro
Patriarca, Francesca
Tosetto, Alberto
Zambello, Renato
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S106 - S107
[7] Translocation t(14;16) in multiple myeloma: gangster or just part of the gang?
Mian, Hira
Kaiser, Martin
Fonseca, Rafael
BLOOD CANCER JOURNAL, 2024, 14 (01)
[8] Translocation t(14;16) in multiple myeloma: gangster or just part of the gang?
Hira Mian
Martin Kaiser
Rafael Fonseca
Blood Cancer Journal, 14
[9] Still high risk? A review of translocation t(14;16) in multiple myeloma
Mian, Hira
Kaiser, Martin
Fonseca, Rafael
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (10) : 1979 - 1987
[10] Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents
Sato, Shuku
Kamata, Wataru
Okada, Satomi
Tamai, Yotaro
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (02) : 207 - 213

← 1 2 3 4 5 →